HOURS
Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed
At Protheragen BioNucleics, we specialize in providing comprehensive solutions for oligonucleotide-based therapeutic development. Our expertise extends to advanced aptamer synthesis, a critical tool in drug development and diagnostic applications. Explore our Oligonucleotide Drugs CRO and Oligonucleotide Sequence Synthesis Service for more information on how we support your research needs.
Aptamers are short, single-stranded DNA or RNA molecules that bind to specific targets with high affinity and specificity. synthesized through an iterative process known as systematic evolution of ligands by exponential enrichment (SELEX), aptamers offer several advantages over traditional antibodies, including smaller size, lower immunogenicity, and ease of chemical modification. These properties make them invaluable in various biomedical applications.
As an ISO9001 certified supplier, Protheragen BioNucleics offers a full spectrum of aptamer synthesis services tailored to your project's requirements.
We provide bespoke aptamer sequences designed using advanced bioinformatics tools. Our team ensures optimal binding characteristics by target analysis, sequence optimization, and chemical modifications.
Our expertise in SELEX library construction enables the generation of high-diversity nucleic acid libraries:
We employ state-of-the-art in vitro SELEX techniques to isolate aptamers against a wide range of targets:
Our services include comprehensive characterization to validate aptamer functionality:
We offer scalable synthesis solutions to meet your production needs:
Enhance the functionality of your aptamers with our conjugation services:
Q1. What information is required to initiate an aptamer synthesis project?
We need details about your target molecule, including its structure and desired binding characteristics. Any specific modifications or applications for the aptamer should also be communicated.
Q2. Can you modify existing aptamers to improve their performance?
Yes, we offer optimization services for existing aptamers, including sequence modification and chemical alterations to enhance stability and affinity.
Q3. How do you ensure the quality and purity of synthesized aptamers?
Our synthesis and purification processes include stringent quality control measures, such as HPLC and mass spectrometry, to guarantee high purity and conformity to specifications.
Targeting specific proteins or cells in disease treatment.
Serving as biosensors for detecting biomarkers.
Facilitating targeted delivery of therapeutics.
Acting as molecular probes in biochemical assays.
Our services and products are exclusively for authorized organizations in research, development, or manufacturing and are not intended for direct use by individuals or patients or as medical advice, diagnosis, or treatment.